A O’Grady - Concepedia

Author

A O’Grady

Beaumont Hospital

Also Known As

A J O’Grady, A O'Grady, A O'grady, A OGRADY, A O’Grady, A. O'Grady, A. OʼGrady, A. O’Grady, A. O’grady, A.J. O'Grady

Publications

Citations

H-Index

Concepts

All Affiliations

Beaumont Hospital Royal College of Surgeons in Ireland St. Vincent's University Hospital University College Dublin University Hospital of Wales

About

A O’Grady is an author at Beaumont Hospital specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	280
2	Public Health	2	2	28
3	Engineering	1	1	33
4	Anatomy	1	1	27
5	Biochemistry	1	1	29

A O’Grady

Publications

983

Citations

H-Index

Page 1

	Year	Citations
The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue Olabode Oladipo, S. Conlon, A O’Grady, British Journal of Cancer	2011	92
Differential expression of matrix metalloproteinase (MMP)‐2, MMP‐9 and tissue inhibitor of metalloproteinase (TIMP)‐1 and TIMP‐2 in non‐melanoma skin cancer: implications for tumour progression A O’Grady, Cara Dunne, Patrick O’Kelly, Histopathology	2007	87
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods J. M. S. Bartlett, Jane Starczynski, Neil Atkey, Journal of Clinical Pathology Reproductive SciencesBreast OncologyPathologySurgeryHer2 Ish	2011	77
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study Julie A. Gormley, Shauna Hegarty, A O’Grady, British Journal of Cancer	2011	71
Cell encapsulation within PVA-based hydrogels via freeze-thawing: a one-step scaffold formation and cell storage technique Nihal Engin Vrana, A O’Grady, E. Kay, Journal of Tissue Engineering and Regenerative Medicine	2009	62
Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma Claire L. Donohoe, Suzanne L. Doyle, Sarah A. McGarrigle, British journal of surgery	2012	53
The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers Robert W. Foley, Laure Marignol, Arun Z. Thomas, Cancer Biology & Therapy	2009	49
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib Naomi Elster, Mattia Cremona, Clare Morgan, Breast Cancer Research and Treatment Radiation OncologyBreast OncologyHer2-targeted Therapies TrastuzumabPreclinical EvaluationMedicine	2014	48
Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential Brian Flood, Katarzyna Oficjalska, Debby Laukens, Clinical & Experimental Immunology	2015	47
The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer Khairun I. Abdul-Jalil, Katherine M. Sheehan, Joan Kehoe, Colorectal Disease	2013	47

Page 1